Xingfang Liu
Overview
Explore the profile of Xingfang Liu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
20
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhu Y, Li Z, Liu X, Wen C
Front Genet
. 2024 Sep;
15:1336728.
PMID: 39296546
Background: While the hepatic enzymes Aspartate Aminotransferase (AST) and Alanine Aminotransferase (ALT) are crucial for liver function, their role in Spontaneous Abortion (SA) has not been thoroughly explored. Utilizing Mendelian...
2.
Pei Y, Yuan W, Li Y, Guo N, Zhang X, Liu X
Micromachines (Basel)
. 2024 Jun;
15(6).
PMID: 38930635
To address surface morphological defects that have a destructive effect on the epitaxial wafer from the aspect of 4H-SiC epitaxial growth, this study thoroughly examined many key factors that affect...
3.
Yang S, Guo N, Zhao S, Li Y, Wei M, Zhang Y, et al.
Materials (Basel)
. 2024 Jun;
17(11).
PMID: 38893876
In this study, we systematically explore the impact of C/Si ratio, pre-carbonization time, H etching time, and growth pressure on the buffer layer and subsequent epitaxial layer of 6-inch 4H-SiC...
4.
Yuan W, Pei Y, Li Y, Guo N, Zhang X, Liu X
Micromachines (Basel)
. 2024 May;
15(5).
PMID: 38793173
In this study, a 4H-SiC homoepitaxial layer was grown on a 150 mm 4° off-axis substrate using a horizontal hot wall chemical vapor deposition reactor. Comparing CH and CH as...
5.
Guo N, Pei Y, Yuan W, Li Y, Zhao S, Yang S, et al.
RSC Adv
. 2024 May;
14(23):16574-16583.
PMID: 38779386
In this study, the epitaxial growth of 6-inch n-type 4° off-axis -face substrates using a horizontal hot-wall LPCVD system was investigated. The study explored the epitaxial growth under different source...
6.
Fu Y, Wang Y, Li Z, Huang K, Gao Y, Xu S, et al.
Front Pharmacol
. 2024 Apr;
15:1325607.
PMID: 38606175
Diabetic peripheral neuropathy (DPN) stands as a crucial complication of diabetes, significantly affecting patients' quality of life. This study aims to elucidate the evidence distribution from clinical randomized controlled trials...
7.
Gao Y, Li Z, Wang Y, Zhang H, Huang K, Fu Y, et al.
Front Endocrinol (Lausanne)
. 2024 Apr;
15:1324782.
PMID: 38601203
Objective: This study aims to map evidence from Randomized Controlled Trials (RCTs) and systematic reviews/Meta-analyses concerning the treatment of Diabetic Nephropathy (DN) with Traditional Chinese Medicine (TCM), understand the distribution...
8.
Cui L, Liu X, Li Y, Jing T, Liu D, Ren C, et al.
Front Pharmacol
. 2024 Apr;
15:1321405.
PMID: 38560355
The co-administration of Chinese patent medicine with calcium channel blockers (CCBs) is a prevalent practice in China for treating essential hypertension (EH). However, robust evidence supporting the efficacy and safety...
9.
Yin T, Zhang H, Liu X, Wei D, Ren C, Cui L, et al.
Front Chem
. 2024 Mar;
12:1356458.
PMID: 38496269
With the increasing global prevalence of hypertension, a condition that can severely affect multiple organs, there is a growing need for effective treatment options. Uncaria rhynchophylla-Alisma plantago-aquatica L. (UR-AP) is...
10.
Yang G, Wang G, Li Z, Deng L, Wang N, Wang X, et al.
Front Pharmacol
. 2024 Feb;
15:1285946.
PMID: 38318142
To compare the intervention effects and pharmacoeconomic advantages of Fufang Huangbai Fluid (FFHB) hydropathic compress Antimicrobial Calcium Alginate Wound Dressing (ACAWD) in the treatment of diabetic foot infections (DFI). Patients...